Historical record - last NADAC effective date: 7/22/2020
Product Information
LOVASTATIN 10 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0597 per EA under NDC 68001031408. Its NADAC has been published 144 times since Nov 1, 2017.
FDA first approved this application on Nov 1, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001031408
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
7/22/2020
Active Ingredients
LOVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA078296FDA Approved
11/1/2007
TE Code
AB
On Market Since
11/1/2007
Pharmacological Classes
Price Statistics
The NADAC for LOVASTATIN 10 MG TABLET has been published 144 times since Nov 1, 2017, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0597 per EA |
|---|---|
| All-time high | $0.0696 (Apr 15, 2020) |
| All-time low | $0.0465 (Apr 17, 2019) |
| Median price | $0.0550 |
| Average price | $0.0556 |
| Largest weekly change | +26.2% (Mar 18, 2020) |
| Weeks tracked | 144 |
| Tracking since | Nov 1, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+2.0%
Last surveyed Jul 29, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOVASTATIN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LOVASTATIN 10 MG TABLET, manufactured by BluePoint Laboratories, is $0.0597 per EA (NDC 68001031408), effective Jul 29, 2020.
How has the price of LOVASTATIN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for LOVASTATIN 10 MG TABLET has held within roughly two percent of its current level. It has been tracked across 144 weekly CMS publications since Nov 1, 2017.
What are the highest and lowest recorded NADAC prices for LOVASTATIN 10 MG TABLET?
Since Nov 1, 2017, the NADAC for LOVASTATIN 10 MG TABLET has ranged from a low of $0.0465 (Apr 17, 2019) to a high of $0.0696 (Apr 15, 2020), with a median of $0.0550 per EA.
Are there cheaper alternatives to LOVASTATIN 10 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOVASTATIN 10 MG TABLET, is $0.0372 per EA — about 38% below LOVASTATIN 10 MG TABLET.
Who manufactures LOVASTATIN 10 MG TABLET?
LOVASTATIN 10 MG TABLET (NDC 68001031408) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.